Aspen Pharmacare Holdings Equity 2024

Aspen Pharmacare Holdings Aktienanalyse

What does Aspen Pharmacare Holdings do?

Aspen Pharmacare Holdings Ltd is a South African company that was founded in 1850 in Durban, South Africa. The company is now one of the largest manufacturers and suppliers of generic drugs in the world and employs over 10,000 people in 55 countries. The company's history dates back to its founder, William Waddell, who opened a pharmacy in Durban in 1850. Over the years, the pharmacy grew into a significant company in the region and expanded to other parts of South Africa in the 1930s. In 1997, the company was renamed Aspen Pharmacare Holdings and began focusing on the production of generic drugs. Aspen Pharma follows a diversified business model based on three pillars: generics, brands, and specialty pharmaceuticals. The company is one of the largest generic drug manufacturers in the world and offers a wide range of generics, including antibiotics, antidepressants, antidiabetics, and cardiovascular medications. The second pillar of the business model is the work in the branded pharmaceuticals sector. For this purpose, Aspen Pharmacare Holdings has a subsidiary called Aspen Global Incorporated, which is responsible for the development, approval, and marketing of patented drugs. Some of Aspen's most well-known branded products include Thrombophob, Emdocam, Bouchara-Recordati, and Zocor. The third pillar of the business model is the specialty pharmaceuticals segment. Here, the company offers medications for specific therapy areas such as cancer, multiple sclerosis, HIV/AIDS, and eye diseases. The company also has its own research and development department to develop and market new drugs. In recent years, Aspen Pharmacare Holdings has experienced impressive expansion. The company has conducted numerous acquisitions and mergers to increase its market presence and diversify its product range. An example of a significant acquisition by Aspen is the purchase of Australian company Sigma Pharmaceuticals in 2011. Through the acquisition of Sigma, Aspen was able to strengthen its role in the Australian market and improve its position in the global pharmaceutical market. In addition to manufacturing and selling drugs, the company also operates a range of other business areas. These include the production of medical devices, the development of medical technology, the manufacturing of biological drugs, and the provision of logistics and distribution services. The company is present in many third-world countries and aims to improve access to affordable medicines worldwide. Aspen has earned an excellent reputation as a pioneer in this field and has been actively involved in numerous projects and initiatives for years to improve healthcare in developing countries. In conclusion, Aspen Pharmacare Holdings is an impressive company with a long history and an extremely diverse product range. The company demonstrates strong growth dynamics while also advocating for improving public health and access to affordable medicines. Given the constantly changing healthcare industry and global threats posed by pandemics and other challenges, Aspen still has significant potential for growth, and the future looks promising. Aspen Pharmacare Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Aspen Pharmacare Holdings's Equity

Aspen Pharmacare Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aspen Pharmacare Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aspen Pharmacare Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aspen Pharmacare Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aspen Pharmacare Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aspen Pharmacare Holdings stock

What is the equity of Aspen Pharmacare Holdings this year?

Aspen Pharmacare Holdings has equity of 86.24 B ZAR this year.

What was the equity of Aspen Pharmacare Holdings compared to the previous year?

The equity of Aspen Pharmacare Holdings has increased/decreased by 21.56% increased compared to the previous year.

What impact does a high equity have on investors of Aspen Pharmacare Holdings?

A high equity is advantageous for investors of Aspen Pharmacare Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Aspen Pharmacare Holdings?

A low equity can be a risk for investors of Aspen Pharmacare Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Aspen Pharmacare Holdings affect the company?

An increase in equity of Aspen Pharmacare Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Aspen Pharmacare Holdings affect the company?

A reduction in equity of Aspen Pharmacare Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Aspen Pharmacare Holdings?

Some factors that can affect the equity of Aspen Pharmacare Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Aspen Pharmacare Holdings so important for investors?

The equity of Aspen Pharmacare Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Aspen Pharmacare Holdings take to change the equity?

To change equity, Aspen Pharmacare Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Aspen Pharmacare Holdings pay?

Over the past 12 months, Aspen Pharmacare Holdings paid a dividend of 3.42 ZAR . This corresponds to a dividend yield of about 0.02 %. For the coming 12 months, Aspen Pharmacare Holdings is expected to pay a dividend of 3.66 ZAR.

What is the dividend yield of Aspen Pharmacare Holdings?

The current dividend yield of Aspen Pharmacare Holdings is 0.02 %.

When does Aspen Pharmacare Holdings pay dividends?

Aspen Pharmacare Holdings pays a quarterly dividend. This is distributed in the months of October, October, October, October.

How secure is the dividend of Aspen Pharmacare Holdings?

Aspen Pharmacare Holdings paid dividends every year for the past 7 years.

What is the dividend of Aspen Pharmacare Holdings?

For the upcoming 12 months, dividends amounting to 3.66 ZAR are expected. This corresponds to a dividend yield of 0.02 %.

In which sector is Aspen Pharmacare Holdings located?

Aspen Pharmacare Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aspen Pharmacare Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspen Pharmacare Holdings from 9/23/2024 amounting to 0.2 ZAR, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Aspen Pharmacare Holdings pay the last dividend?

The last dividend was paid out on 9/23/2024.

What was the dividend of Aspen Pharmacare Holdings in the year 2023?

In the year 2023, Aspen Pharmacare Holdings distributed 3.26 ZAR as dividends.

In which currency does Aspen Pharmacare Holdings pay out the dividend?

The dividends of Aspen Pharmacare Holdings are distributed in ZAR.